JBIO

Jade Biosciences Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 4/10
  • Value↑ 5/10
Jade Biosciences sales and earnings growth
JBIO Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 96.23%
  • FCF Y/Y↓ -104.40%
Jade Biosciences gross and profit margin trends
JBIO Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -115.94%
Jade Biosciences recent dividend growth
JBIO Dividends
  • Dividend yield 0.00%
  • Growth 3Y↓ 0.00%
  • Payout ratio↑ -119%
Jade Biosciences net debt vs free cash flow
JBIO Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Jade Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks